[Skip to content]

Database

The CASH Database

The database is the hub of the CASH service. The content can be added, searched and exported to create personalised alerting services for library customers.  There are a number of newsfeeds that can be embedded into external CAS website pages keeping them constantly updated with the latest content.

To search for a specific item enter a keyword that may appear in either the title or summary.

Database entry is very quick and easy, see the Database Quick Guide for further support.

Search Tips

  • Search for the first three words in the title e.g. "Five year forward" will find everything about the Five Year Forward View
  • Browse a category from the drop-down list to see the latest news on that topic

  • Enter a keyword to narrow your search e.g. Category Mental Health and Keyword Parity 

Aducanumab for Alzheimer’s disease: expediting approval and delaying science

Source
Salinas RA BMJ Evidence-Based Medicine Published Online First: 14 July 2021. doi: 10.1136/bmjebm-202
Year of publication
2021
Abstract
At the beginning of this month of June, the Food and Drug Administration (FDA) announced its decision to grant marketing authorisation to the monoclonal antibody aducanumab, the first treatment option targeting and affecting the underlying disease process of Alzheimer’s disease, according to the press release of the medicines regulatory agency of the USA. What should have been a source of joy and recognition of the success of basic and clinical sciences, however, resulted in a bitter dispute in the scientific community, that ended up in the resignation of three of the experts who had participated in the committee that advised the agency on the safety and efficacy of this new drug.
Date added
22/07/2021
Created by
Meara Brooks
Published by
Current Awareness Service for Health